CEO commentary: Northeastern University’s participation at Engineering and Physical Sciences in Oncology
On PHI’s website, founder and CEO Peter Egelberg comments on Northeastern University’s participation at Engineering and Physical Sciences in Oncology in Boston, see www.phiab.se/commentary/commentary-160704.
For additional information, please contact:
Phase Holographic Imaging (PHI) leads the ground-breaking development of time-lapse cytometry instrumentation and software. With the first instrument introduced in 2011, the company today offers a range of products for long-term quantitative analysis of living cell dynamics that circumvent the drawbacks of traditional methods requiring toxic stains. Headquartered in Lund, Sweden, PHI trades through a network of international distributors. Committed to promoting the science and practice of time-lapse cytometry, PHI is actively expanding its customer base and scientific collaborations in cancer research, inflammatory and autoimmune diseases, stem cell biology, gene therapy, regenerative medicine and toxicological studies.